M05.359

Clinical Causes: Autoimmune response where the immune system mistakenly attacks synovial tissues in joints and the heart. Genetic predisposition leading to increased susceptibility to autoimmune conditions. Environmental factors such as smoking or exposure to certain infections that may trigger immune dysregulation. Chronic inflammation associated with rheumatoid arthritis which can affect cardiovascular tissues. Poorly controlled RA leading to systemic spread of inflammatory processes.

Key Symptoms: Chest pain or discomfort, often related to inflammation of the heart lining or muscle. Shortness of breath, particularly during exertion or when lying down. Fatigue and weakness due to decreased cardiac efficiency. Palpitations or irregular heartbeats caused by cardiac involvement. Swelling in the feet, ankles, or legs as a sign of heart failure. Joint pain, swelling, or stiffness in the hips and other joints affected by RA. Persistent cough or low-grade fever associated with systemic inflammation.

Diagnosis Path: Medical history review focusing on joint symptoms and cardiovascular issues. Physical examinations assessing joint swelling, warmth, and range of motion. Blood tests including rheumatoid factor (RF), anti-CCP antibodies, ESR, and CRP to evaluate inflammation and autoimmune activity. Electrocardiogram (ECG) to detect arrhythmias or signs of heart inflammation. Echocardiography to visualize heart structure and function, identifying pericarditis, myocarditis, or valvular issues. Imaging studies like X-rays or MRI of affected joints to assess RA severity. Additional tests as needed, like cardiac MRI or stress testing, to evaluate cardiac health more thoroughly.

Treatment Protocols: Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, to control RA activity and prevent joint damage. Biologic agents targeting specific immune pathways to reduce systemic inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids to alleviate pain and inflammation. Medications specifically for cardiac issues, such as ACE inhibitors, beta-blockers, or diuretics, based on heart function. Lifestyle modifications including a balanced diet, regular exercise, smoking cessation, and weight management to lessen cardiovascular risk. Regular monitoring of disease activity and cardiac function through clinical assessments and imaging. Physical and occupational therapy to maintain joint mobility and function.